These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 923329)

  • 21. Application of cephalosporins to obstetrics and gynecology: transfer of cefazolin and cephalothin to uterine tissue.
    Yamada N; Kido K; Uchida H; Yano J; Sagawa N; Hayashi S
    Am J Obstet Gynecol; 1980 Apr; 136(8):1036-40. PubMed ID: 7369254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of cephalothin, cephaloridine and cefazolin to human serum proteins.
    Miyake Y; Ebata M
    J Antibiot (Tokyo); 1976 Jun; 29(6):667. PubMed ID: 950323
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of cefazolin compared with four other cephalosporins.
    Kirby WM; Regamey C
    J Infect Dis; 1973 Oct; 128():Suppl:S341-6. PubMed ID: 4744015
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.
    Philipson A; Stiernstedt G; Ehrnebo M
    Clin Pharmacokinet; 1987 Feb; 12(2):136-44. PubMed ID: 3829560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cephacetrile in the treatment of acute bacterial pneumonia.
    Fee WH; Winter LW; Bright TP; Smith JW; Farber MO; Bartram CE
    Curr Ther Res Clin Exp; 1975 May; 17(5):419-26. PubMed ID: 236153
    [No Abstract]   [Full Text] [Related]  

  • 27. Long half-life for cefazolin in anuria.
    Moore TD; Seth SK
    Ann Intern Med; 1978 Feb; 88(2):269-70. PubMed ID: 626466
    [No Abstract]   [Full Text] [Related]  

  • 28. Cefazedone: microbiological evaluation in comparison with cephalothin and cefazolin.
    Wahlig H; Dingeldein E; Mitsuhashi S; Kawabe H
    Arzneimittelforschung; 1979; 29(2a):369-78. PubMed ID: 582712
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative clinical pharmacology of intravenous cefoxitin and cephalothin.
    Sonneville PF; Kartodirdjo RR; Skeggs H; Till AE; Martin CM
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):397-403. PubMed ID: 971703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin.
    Pabst J; Leopold G; Ungethüm W; Dingeldein E
    Arzneimittelforschung; 1979; 29(2a):437-43. PubMed ID: 582722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.
    Andriole VT
    J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.
    Cahn MM; Levy EJ; Actor P; Pauls JF
    J Clin Pharmacol; 1974 Jan; 14(1):61-6. PubMed ID: 4588120
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of cefazolin patients with normal and impaired renal function.
    Bergan T; Brodwall EK; Orjavik O
    J Antimicrob Chemother; 1977 Sep; 3(5):435-43. PubMed ID: 903324
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative pharmacokinetic studies of cephapirin and cephalothin following intravenous and intramuscular administration.
    Lane AZ; Chudzik GM; Siskin SB
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):117-27. PubMed ID: 401706
    [No Abstract]   [Full Text] [Related]  

  • 35. Cefazolin concentrations in bone and synovial fluid.
    Schurman DJ; Hirshman HP; Kajiyama G; Moser K; Burton DS
    J Bone Joint Surg Am; 1978 Apr; 60(3):359-62. PubMed ID: 649639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cephalosporin antibiotics: protein-binding considerations.
    Singhvi SM; Heald AF; Schreiber EC
    Chemotherapy; 1978; 24(3):121-33. PubMed ID: 657874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and bioavailability of cefazolin in horses.
    Sams RA; Ruoff WW
    Am J Vet Res; 1985 Feb; 46(2):348-52. PubMed ID: 3994100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on chemotherapy during the perinatal period with special reference to such derivatives of cephalosporin C as cefazolin, cephaloridine and cephalothin.
    Fukada M
    Jpn J Antibiot; 1973 Jun; 26(3):197-214. PubMed ID: 4542543
    [No Abstract]   [Full Text] [Related]  

  • 39. Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.
    Polk RE; Kline BJ; Markowitz SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):576-9. PubMed ID: 6459759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biliary tract kinetics of some cephalosporin antibiotics.
    Trachtenberg L; Fagelman KM; Polk HC
    Surgery; 1978 Sep; 84(3):342-7. PubMed ID: 684625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.